Click here to get full coverage on AngioDynamics (ANGO) Q1 2025 Earnings Transcript - AOL.com

AngioDynamics (ANGO) Q1 2025 Earnings Transcript  AOL.com

AngioDynamics (ANGO) Q1 2025 Earnings Transcript - AOL.com

Click here to get full coverage on AngioDynamics Inc (ANGO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

AngioDynamics Inc (ANGO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...  Yahoo Finance

AngioDynamics Inc (ANGO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Click here to get full coverage on ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves - Zacks Investment Research

ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves  Zacks Investment Research

ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves - Zacks Investment Research

Click here to get full coverage on Assessing AngioDynamics (ANGO) Valuation After Raised Guidance And Med Tech Momentum - Sahm

Assessing AngioDynamics (ANGO) Valuation After Raised Guidance And Med Tech Momentum  Sahm

Assessing AngioDynamics (ANGO) Valuation After Raised Guidance And Med Tech Momentum - Sahm

Click here to get full coverage on AngioDynamics (ANGO) EPS Loss Of US$0.26 Tests Optimistic Profit Turnaround Narratives - simplywall.st

AngioDynamics (ANGO) EPS Loss Of US$0.26 Tests Optimistic Profit Turnaround Narratives  simplywall.st

AngioDynamics (ANGO) EPS Loss Of US$0.26 Tests Optimistic Profit Turnaround Narratives - simplywall.st

Click here to get full coverage on ANGIODYNAMICS Q2 2026 Earnings Preview: Recent $ANGO Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

ANGIODYNAMICS Q2 2026 Earnings Preview: Recent $ANGO Insider Trading, Hedge Fund Activity, and More  Quiver Quantitative

ANGIODYNAMICS Q2 2026 Earnings Preview: Recent $ANGO Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Click here to get full coverage on Why AngioDynamics Stock Is Sinking Today - The Motley Fool

Why AngioDynamics Stock Is Sinking Today  The Motley Fool

Why AngioDynamics Stock Is Sinking Today - The Motley Fool

Click here to get full coverage on H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $16 - 富途资讯

H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $16  富途资讯

H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $16 - 富途资讯

Click here to get full coverage on Obsidian’s CEO on why productivity tools need community more than AI - The Verge

Obsidian’s CEO on why productivity tools need community more than AI  The Verge

Obsidian’s CEO on why productivity tools need community more than AI - The Verge

Click here to get full coverage on $ANGO stock is down 15% today. Here's what we see in our data. - Quiver Quantitative

$ANGO stock is down 15% today. Here's what we see in our data.  Quiver Quantitative

$ANGO stock is down 15% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Assessing AngioDynamics (ANGO) Valuation After Raised Guidance And Med Tech Momentum - simplywall.st

Assessing AngioDynamics (ANGO) Valuation After Raised Guidance And Med Tech Momentum  simplywall.st

Assessing AngioDynamics (ANGO) Valuation After Raised Guidance And Med Tech Momentum - simplywall.st

Click here to get full coverage on ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves - Zacks Investment Research

ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves  Zacks Investment Research

ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves - Zacks Investment Research

Click here to get full coverage on Is AngioDynamics' (ANGO) Higher Sales Guidance Enough To Offset CEO Transition Concerns? - Yahoo Finance

Is AngioDynamics' (ANGO) Higher Sales Guidance Enough To Offset CEO Transition Concerns?  Yahoo Finance

Is AngioDynamics' (ANGO) Higher Sales Guidance Enough To Offset CEO Transition Concerns? - Yahoo Finance

Click here to get full coverage on Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO) - Yahoo Finance

Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO)  Yahoo Finance

Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO) - Yahoo Finance

Click here to get full coverage on AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates  Yahoo Finance

AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on AngioDynamics (ANGO): Losses Worsen, but Forecasted 62% Earnings Growth Challenges Bearish Narratives - Yahoo Finance

AngioDynamics (ANGO): Losses Worsen, but Forecasted 62% Earnings Growth Challenges Bearish Narratives  Yahoo Finance

AngioDynamics (ANGO): Losses Worsen, but Forecasted 62% Earnings Growth Challenges Bearish Narratives - Yahoo Finance

Click here to get full coverage on AngioDynamics Stock (ANGO) Opinions on CEO Share Purchase | ANGO Stock News - Quiver Quantitative

AngioDynamics Stock (ANGO) Opinions on CEO Share Purchase | ANGO Stock News  Quiver Quantitative

AngioDynamics Stock (ANGO) Opinions on CEO Share Purchase | ANGO Stock News - Quiver Quantitative

Click here to get full coverage on AngioDynamics: Growth Remains Under The Radar (NASDAQ:ANGO) - Seeking Alpha

AngioDynamics: Growth Remains Under The Radar (NASDAQ:ANGO)  Seeking Alpha

AngioDynamics: Growth Remains Under The Radar (NASDAQ:ANGO) - Seeking Alpha

Click here to get full coverage on AngioDynamics Inc (ANGO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff ... - Yahoo Finance

AngioDynamics Inc (ANGO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff ...  Yahoo Finance

AngioDynamics Inc (ANGO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff ... - Yahoo Finance

Click here to get full coverage on Earnings To Watch: AngioDynamics Inc (ANGO) Reports Q1 2026 Result - Yahoo Finance

Earnings To Watch: AngioDynamics Inc (ANGO) Reports Q1 2026 Result  Yahoo Finance

Earnings To Watch: AngioDynamics Inc (ANGO) Reports Q1 2026 Result - Yahoo Finance

Click here to get full coverage on ANGO Stock Down Despite Q4 Earnings Beat, Gross Margin Declines - Yahoo Finance

ANGO Stock Down Despite Q4 Earnings Beat, Gross Margin Declines  Yahoo Finance

ANGO Stock Down Despite Q4 Earnings Beat, Gross Margin Declines - Yahoo Finance

Click here to get full coverage on What To Expect From AngioDynamics Inc (ANGO) Q4 2025 Earnings - Yahoo Finance

What To Expect From AngioDynamics Inc (ANGO) Q4 2025 Earnings  Yahoo Finance

What To Expect From AngioDynamics Inc (ANGO) Q4 2025 Earnings - Yahoo Finance

Click here to get full coverage on AngioDynamics' (NASDAQ:ANGO) investors will be pleased with their notable 77% return over the last year - Yahoo Finance

AngioDynamics' (NASDAQ:ANGO) investors will be pleased with their notable 77% return over the last year  Yahoo Finance

AngioDynamics' (NASDAQ:ANGO) investors will be pleased with their notable 77% return over the last year - Yahoo Finance

Click here to get full coverage on Insider Purchase: SVP of $ANGO Buys 10,000 Shares | ANGO Stock News - Quiver Quantitative

Insider Purchase: SVP of $ANGO Buys 10,000 Shares | ANGO Stock News  Quiver Quantitative

Insider Purchase: SVP of $ANGO Buys 10,000 Shares | ANGO Stock News - Quiver Quantitative

Click here to get full coverage on AngioDynamics (ANGO) Q2 2026 Earnings Transcript - AOL.com

AngioDynamics (ANGO) Q2 2026 Earnings Transcript  AOL.com

AngioDynamics (ANGO) Q2 2026 Earnings Transcript - AOL.com

Click here to get full coverage on H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance - Yahoo Finance

H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance  Yahoo Finance

H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance - Yahoo Finance

Click here to get full coverage on Angiodynamics (ANGO) CEO Clemmer buys $111,500 in shares - Investing.com

Angiodynamics (ANGO) CEO Clemmer buys $111,500 in shares  Investing.com

Angiodynamics (ANGO) CEO Clemmer buys $111,500 in shares - Investing.com

Click here to get full coverage on AngioDynamics (NASDAQ:ANGO) Issues Quarterly Earnings Results - MarketBeat

AngioDynamics (NASDAQ:ANGO) Issues Quarterly Earnings Results  MarketBeat

AngioDynamics (NASDAQ:ANGO) Issues Quarterly Earnings Results - MarketBeat

Click here to get full coverage on ANGO: Med Tech growth and raised guidance highlight strong Q2 FY26 performance - TradingView — Track All Markets

ANGO: Med Tech growth and raised guidance highlight strong Q2 FY26 performance  TradingView — Track All Markets

ANGO: Med Tech growth and raised guidance highlight strong Q2 FY26 performance - TradingView — Track All Markets

Click here to get full coverage on AngioDynamics (NASDAQ:ANGO) Releases FY 2026 Earnings Guidance - MarketBeat

AngioDynamics (NASDAQ:ANGO) Releases FY 2026 Earnings Guidance  MarketBeat

AngioDynamics (NASDAQ:ANGO) Releases FY 2026 Earnings Guidance - MarketBeat

Click here to get full coverage on What to Expect from AngioDynamics's Earnings - Benzinga

What to Expect from AngioDynamics's Earnings  Benzinga

What to Expect from AngioDynamics's Earnings - Benzinga

Click here to get full coverage on Aug Fed Impact: Is ANGO a top pick in the sector - July 2025 WrapUp & Daily Profit Focused Screening - baoquankhu1.vn

Aug Fed Impact: Is ANGO a top pick in the sector - July 2025 WrapUp & Daily Profit Focused Screening  baoquankhu1.vn

Aug Fed Impact: Is ANGO a top pick in the sector - July 2025 WrapUp & Daily Profit Focused Screening - baoquankhu1.vn

Click here to get full coverage on AngioDynamics (ANGO) Q3 2025 Earnings Transcript - The Globe and Mail

AngioDynamics (ANGO) Q3 2025 Earnings Transcript  The Globe and Mail

AngioDynamics (ANGO) Q3 2025 Earnings Transcript - The Globe and Mail

Click here to get full coverage on AngioDynamics (ANGO) Q1 2026 Earnings Transcript - The Globe and Mail

AngioDynamics (ANGO) Q1 2026 Earnings Transcript  The Globe and Mail

AngioDynamics (ANGO) Q1 2026 Earnings Transcript - The Globe and Mail

Click here to get full coverage on AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2026 Earnings Call Transcript - Insider Monkey

AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2026 Earnings Call Transcript  Insider Monkey

AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2026 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on AngioDynamics (ANGO) Updates FY26 Revenue and EBITDA Outlook - GuruFocus

AngioDynamics (ANGO) Updates FY26 Revenue and EBITDA Outlook  GuruFocus

AngioDynamics (ANGO) Updates FY26 Revenue and EBITDA Outlook - GuruFocus

Click here to get full coverage on The Market Doesn't Like What It Sees From AngioDynamics, Inc.'s (NASDAQ:ANGO) Revenues Yet - simplywall.st

The Market Doesn't Like What It Sees From AngioDynamics, Inc.'s (NASDAQ:ANGO) Revenues Yet  simplywall.st

The Market Doesn't Like What It Sees From AngioDynamics, Inc.'s (NASDAQ:ANGO) Revenues Yet - simplywall.st

Click here to get full coverage on AngioDynamics (NASDAQ: ANGO) to join UBS Global Healthcare Conference at 8:00 a.m. ET - Stock Titan

AngioDynamics (NASDAQ: ANGO) to join UBS Global Healthcare Conference at 8:00 a.m. ET  Stock Titan

AngioDynamics (NASDAQ: ANGO) to join UBS Global Healthcare Conference at 8:00 a.m. ET - Stock Titan

Click here to get full coverage on AngioDynamics: Discounted Sales Multiple With Real Growth Engines (NASDAQ:ANGO) - Seeking Alpha

AngioDynamics: Discounted Sales Multiple With Real Growth Engines (NASDAQ:ANGO)  Seeking Alpha

AngioDynamics: Discounted Sales Multiple With Real Growth Engines (NASDAQ:ANGO) - Seeking Alpha

Click here to get full coverage on New York medtech firm to present at J.P. Morgan healthcare conference - Stock Titan

New York medtech firm to present at J.P. Morgan healthcare conference  Stock Titan

New York medtech firm to present at J.P. Morgan healthcare conference - Stock Titan

Click here to get full coverage on AngioDynamics CEO, President & Director Acquires 1.9% More Stock - simplywall.st

AngioDynamics CEO, President & Director Acquires 1.9% More Stock  simplywall.st

AngioDynamics CEO, President & Director Acquires 1.9% More Stock - simplywall.st

Click here to get full coverage on Discipline and Rules-Based Execution in ANGO Response - Stock Traders Daily

Discipline and Rules-Based Execution in ANGO Response  Stock Traders Daily

Discipline and Rules-Based Execution in ANGO Response - Stock Traders Daily

Click here to get full coverage on AngioDynamics: A MedTech Powerhouse Emerging From Legacy Overhaul (NASDAQ:ANGO) - Seeking Alpha

AngioDynamics: A MedTech Powerhouse Emerging From Legacy Overhaul (NASDAQ:ANGO)  Seeking Alpha

AngioDynamics: A MedTech Powerhouse Emerging From Legacy Overhaul (NASDAQ:ANGO) - Seeking Alpha

Click here to get full coverage on Lake Street Initiates AngioDynamics(ANGO.US) With Buy Rating, Announces Target Price $24 - 富途资讯

Lake Street Initiates AngioDynamics(ANGO.US) With Buy Rating, Announces Target Price $24  富途资讯

Lake Street Initiates AngioDynamics(ANGO.US) With Buy Rating, Announces Target Price $24 - 富途资讯

Click here to get full coverage on Buyout Rumor: Whats the fair value of ANGO stock - 2025 Institutional Moves & Technical Pattern Recognition Alerts - baoquankhu1.vn

Buyout Rumor: Whats the fair value of ANGO stock - 2025 Institutional Moves & Technical Pattern Recognition Alerts  baoquankhu1.vn

Buyout Rumor: Whats the fair value of ANGO stock - 2025 Institutional Moves & Technical Pattern Recognition Alerts - baoquankhu1.vn

Click here to get full coverage on CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $18 - 富途资讯

CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $18  富途资讯

CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $18 - 富途资讯

Click here to get full coverage on AngioDynamics (ANGO) Down 6.4% Since Last Earnings Report: Can It Rebound? - Nasdaq

AngioDynamics (ANGO) Down 6.4% Since Last Earnings Report: Can It Rebound?  Nasdaq

AngioDynamics (ANGO) Down 6.4% Since Last Earnings Report: Can It Rebound? - Nasdaq

Click here to get full coverage on Shakshouka w/ Ango 14th May 2025 - NTS Radio

Shakshouka w/ Ango 14th May 2025  NTS Radio

Shakshouka w/ Ango 14th May 2025 - NTS Radio

Click here to get full coverage on Will ANGO stock attract more institutional investors - July 2025 Chart Watch & Weekly Chart Analysis and Guides - ulpravda.ru

Will ANGO stock attract more institutional investors - July 2025 Chart Watch & Weekly Chart Analysis and Guides  ulpravda.ru

Will ANGO stock attract more institutional investors - July 2025 Chart Watch & Weekly Chart Analysis and Guides - ulpravda.ru

Click here to get full coverage on Ango Abdul Samed's last minute header hands Northbengal United three points - Tribune India

Ango Abdul Samed's last minute header hands Northbengal United three points  Tribune India

Ango Abdul Samed's last minute header hands Northbengal United three points - Tribune India

Click here to get full coverage on Biggest stock movers Wednesday: NCNO, TTEC, EWTX, BB, ANGO and more - MSN

Biggest stock movers Wednesday: NCNO, TTEC, EWTX, BB, ANGO and more  MSN

Biggest stock movers Wednesday: NCNO, TTEC, EWTX, BB, ANGO and more - MSN

Click here to get full coverage on Ango Sakaguchi Exhibition （Jissen Women's University Shibuya Campus） - Tokyo Art Beat

Ango Sakaguchi Exhibition （Jissen Women's University Shibuya Campus）  Tokyo Art Beat

Ango Sakaguchi Exhibition （Jissen Women's University Shibuya Campus） - Tokyo Art Beat

Click here to get full coverage on Wike sacks acting FCT-IRS chairman Michael Ango - Businessday NG

Wike sacks acting FCT-IRS chairman Michael Ango  Businessday NG

Wike sacks acting FCT-IRS chairman Michael Ango - Businessday NG

Click here to get full coverage on AngioDynamics Stock (ANGO): Surges on Med-Tech Growth, Raises Outlook - Value The Markets

AngioDynamics Stock (ANGO): Surges on Med-Tech Growth, Raises Outlook  Value The Markets

AngioDynamics Stock (ANGO): Surges on Med-Tech Growth, Raises Outlook - Value The Markets

Click here to get full coverage on Ango Abdullahi's son, who won PDP house of reps' ticket while in captivity, resigns from party - TheCable

Ango Abdullahi's son, who won PDP house of reps' ticket while in captivity, resigns from party  TheCable

Ango Abdullahi's son, who won PDP house of reps' ticket while in captivity, resigns from party - TheCable

Click here to get full coverage on In loving memory of Ruqayyah Ali Ango: A light of kindness and grace, By Hadiza Adamu Fika - Premium Times Nigeria

In loving memory of Ruqayyah Ali Ango: A light of kindness and grace, By Hadiza Adamu Fika  Premium Times Nigeria

In loving memory of Ruqayyah Ali Ango: A light of kindness and grace, By Hadiza Adamu Fika - Premium Times Nigeria

Click here to get full coverage on Wike sacks FCT-IRS acting chair — weeks after staff honoured him for exemplary leadership - TheCable

Wike sacks FCT-IRS acting chair — weeks after staff honoured him for exemplary leadership  TheCable

Wike sacks FCT-IRS acting chair — weeks after staff honoured him for exemplary leadership - TheCable

Click here to get full coverage on Wike boots out FCT-IRS acting chairman Michael Ango - PM News Nigeria

Wike boots out FCT-IRS acting chairman Michael Ango  PM News Nigeria

Wike boots out FCT-IRS acting chairman Michael Ango - PM News Nigeria

Click here to get full coverage on Wike Sacks FCT-IRS Acting Chairman, Ango - THISDAYLIVE

Wike Sacks FCT-IRS Acting Chairman, Ango  THISDAYLIVE

Wike Sacks FCT-IRS Acting Chairman, Ango - THISDAYLIVE

Click here to get full coverage on Wike sacks FCT-IRS acting chair - Punch Newspapers

Wike sacks FCT-IRS acting chair  Punch Newspapers

Wike sacks FCT-IRS acting chair - Punch Newspapers

Click here to get full coverage on Rajasthan United announce signing of Ghanaian defender Abdul Samed Ango - GhanaSoccernet

Rajasthan United announce signing of Ghanaian defender Abdul Samed Ango  GhanaSoccernet

Rajasthan United announce signing of Ghanaian defender Abdul Samed Ango - GhanaSoccernet

Click here to get full coverage on Wike Reinstates Education Mandate Secretary, IRS Acting Chairman - Channels Television

Wike Reinstates Education Mandate Secretary, IRS Acting Chairman  Channels Television

Wike Reinstates Education Mandate Secretary, IRS Acting Chairman - Channels Television

Click here to get full coverage on Wike removes Ango, appoints new leadership for FCT Revenue Service - Champion Newspapers LTD

Wike removes Ango, appoints new leadership for FCT Revenue Service  Champion Newspapers LTD

Wike removes Ango, appoints new leadership for FCT Revenue Service - Champion Newspapers LTD

Click here to get full coverage on Ango Urges SDAs to Prioritize Budgetary Support for Livestock Transformation in FCT - the authority news

Ango Urges SDAs to Prioritize Budgetary Support for Livestock Transformation in FCT  the authority news

Ango Urges SDAs to Prioritize Budgetary Support for Livestock Transformation in FCT - the authority news

Click here to get full coverage on Kaduna Rep, Sadiq Ango Abdullahi resigns from PDP - PM News Nigeria

Kaduna Rep, Sadiq Ango Abdullahi resigns from PDP  PM News Nigeria

Kaduna Rep, Sadiq Ango Abdullahi resigns from PDP - PM News Nigeria

Click here to get full coverage on Wike Sacks FCT-IRS Acting Chairman - Channels Television

Wike Sacks FCT-IRS Acting Chairman  Channels Television

Wike Sacks FCT-IRS Acting Chairman - Channels Television

Click here to get full coverage on AngioDynamics: A Surgical Approach To Market Growth (NASDAQ:ANGO) - Seeking Alpha

AngioDynamics: A Surgical Approach To Market Growth (NASDAQ:ANGO)  Seeking Alpha

ANGO

Price Chart

Key Statistics

Technicals

About ANGO

Latest News

AngioDynamics (ANGO) Q1 2025 Earnings Transcript - AOL.com

AngioDynamics Inc (ANGO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves - Zacks Investment Research

Advanced Charts

Top Gainers

Top Losers